AmSurg receives average "buy" rating

Eleven analyst firms have given AmSurg stock an average rating of "buy," according to a report from The Legacy.

AmSurg stock has an average 12-month price target of $67.45. The company's stock has a 50-day moving average of $65 and a 200-day moving average of $58, according to the report.

More articles on transactions and valuation issues:
4 recent orthopedics-driven ASC plans & openings
Ellis Hospital is crowdfunding its new surgery center: 4 insights
Nobilis Healthcare receives $25M loan from GE Capital

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers